Total Funding
35
53
Total FundingGrant raised
Growth Score
-28 pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
190441
For people at diabetic risk, glucose control is at its most crucial while in hospital or surgery.
Glenn Robertelli: Co-Founder & Chief Operating Officer
Timothy Valk: Chief Scientist
About the Company
Admetsys has developed a first-of-its-kind artificial pancreas for hospital and surgical care, leveraging adaptive learning algorithms and counterbalancing treatment of insulin and glucose.
The system has undergone 3 successful FDA-approved clinical trials with 97% control
between 80–125 mg/dl and zero incidents of low blood sugar.
